Search - tctmd.com

Displaying 521 - 540 of 879

Sort: Relevancy | Date

Presentation TCT 2017

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Laura Mauri

October 30, 2017

Presentation TCT 2017

Case #7: Malapposition in a Bioresorbable Scaffold - Identification and the Decision Whether to Treat (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

Presentation TCT 2017

When to Declare Victory

Presenter: John S. Douglas Jr, Valerian Fernandes, Christopher D. Nielsen

October 30, 2017

News Conference News TCT 2017

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Todd Neale

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

Presentation TCT 2017

Decision-making Process When Viewing a CHIP Case

Presenter: Amr Kamal, Mohamed Ahmed Sobhy

October 29, 2017

Presentation TCT 2017

How to Interpret Hemodynamic and Echo Data for Transcatheter Mitral Valve Repair Clinical Decision-making and Procedural Guidance

Presenter: Jeff Davis, James B. Hermiller Jr.

October 29, 2017

Presentation TCT 2017

How to Interpret Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-making and Procedural Guidance

Presenter: Thomas H. Maloney, Paul D. Mahoney

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

News Conference News TCT 2016

TCT Mock Election: And the Winner Is...

Shelley Wood

November 02, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy

November 01, 2016

Presentation TCT 2016

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White

November 01, 2016

Advertisement

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Case #7: Malapposition in a Bioresorbable Scaffold - Identification and the Decision Whether to Treat (With Discussion)

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

When to Declare Victory

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Off Script: Welcome to TCT 2017 in the Mile High City

Decision-making Process When Viewing a CHIP Case

How to Interpret Hemodynamic and Echo Data for Transcatheter Mitral Valve Repair Clinical Decision-making and Procedural Guidance

How to Interpret Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-making and Procedural Guidance

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

TCT Mock Election: And the Winner Is...

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content